About company
Zumbro Discovery, Inc. is developing a novel natriuretic peptide, MANP, for the treatment of resistant hypertension for which there is an unmet medical need for a syndrome which increases risk for heart failure, myocardial infarction, stroke and kidney disease. MANP was discovered at the Mayo Clinic and is soon entering first in human studies.
- Unknown
- Unknown
- Unknown
- zumbrodiscovery.com/
- Not verified company
